• Polyploid Giant Cancer Macrophages: Clinical Utility and Phe

  2026-06-11

  This study establishes circulating phagocytic polyploid giant cancer macrophages (CAMLs) as significant indicators of cancer progression across diverse solid tumors. By characterizing their phenotypic markers and linking their presence to disease spread, the work informs both cancer biology and translational research on metastatic mechanisms.

• Sulfisomidine: Mechanisms, Benchmarks, and Research Protocol

  2026-06-10

  Sulfisomidine (sulfamethin) is a short-acting sulfonamide antibacterial and enzyme kinetics inhibitor with well-characterized effects on microbial and human metabolic pathways. Its efficacy, environmental fate, and roles in oxidative stress regulation research are supported by peer-reviewed evidence and product data. This dossier details its mechanism, benchmarks, and optimal research workflows.

• Cy3-UTP in RNA Condensate Biology: Illuminating LLPS and Vir

  2026-06-10

  Discover how Cy3-UTP empowers advanced fluorescence-based RNA studies, including the dissection of phase-separated RNA-protein condensates relevant to viral replication. This article provides a deep dive into Cy3-modified uridine triphosphate's scientific impact and practical parameters.

• N4-Acetylcytidine in RNA Modification: Protocols & Troublesh

  2026-06-09

  N4-Acetylcytidine from APExBIO empowers precise RNA modification studies, supporting advanced enzyme assays and structural analysis with exceptional purity and solubility. This guide translates recent structural insights into actionable workflows and troubleshooting strategies for robust, reproducible RNA epigenetics research.

• nor-NOHA Acetate: Rewiring Arginine Metabolism for Translati

  2026-06-09

  This article explores the mechanistic and translational significance of nor-NOHA (acetate) as a potent arginase inhibitor, contextualizing its role in cancer biology and vascular research. By bridging foundational metabolic pathways with emerging immunometabolic targets, we offer strategic guidance for researchers aiming to leverage nor-NOHA in advanced experimental models. Drawing upon recent insights into immune escape mechanisms in AML and practical workflow innovations, the discussion highlights how APExBIO’s nor-NOHA acetate empowers translational scientists to dissect and modulate arginine metabolism, with a forward-looking perspective anchored in credible evidence.

• Angiotensin 1/2 (2-7) Peptide: Precision Tools for RAS Resea

  2026-06-08

  Angiotensin 1/2 (2-7) offers unmatched specificity for blood pressure regulation and emerging viral interaction studies. Its robust solubility and high purity streamline experimental workflows, making it a critical asset for advanced renin-angiotensin signaling research.

• Degarelix Acetate: Precision GnRH Antagonist for Research

  2026-06-08

  Degarelix acetate delivers rapid, selective GnRH receptor antagonism for high-fidelity pituitary and prostate cancer research. This guide details optimized workflows, advanced applications, and troubleshooting strategies to unlock reproducible hormone pathway inhibition using APExBIO's trusted formulation.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-07

  Xue et al. provide the first detailed analysis of sex-dependent responses to chronic angiotensin II infusion in conscious mice, demonstrating that male mice develop more severe hypertension than females and identifying the modulatory role of sex hormones and baroreflex function. These findings underline the necessity of including sex as a biological variable in cardiovascular research and inform the design of future studies investigating hypertension mechanisms.

• Primidone (Mysoline): Protocols and Innovations in ALS Resea

  2026-06-06

  Primidone (Mysoline) is redefining translational neurodegenerative research through dual RIPK1 and TRPM3 inhibition, with robust, validated applications in ALS and beyond. This article details actionable workflows and troubleshooting tips for maximizing experimental reliability with APExBIO's trusted compound.

• HyperFluor™ 594 Goat Anti-Rabbit IgG for Advanced Immunofluo

  2026-06-05

  Leverage the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody for precise, high-sensitivity detection in immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA. Discover step-by-step workflows, real-world troubleshooting advice, and insights from breakthrough atherosclerosis research to elevate your experimental outcomes.

• G-1 (CAS 881639-98-1): Dissecting Selective GPR30 Agonism in

  2026-06-05

  Explore the scientific underpinnings of G-1, a selective GPR30 agonist, with an in-depth analysis of its mechanism, selectivity, and translational impact in cardiovascular and oncology research. Discover unique protocol insights and practical considerations for advanced research applications.

• Streptavidin-HyperFluor 647: Precision in Biotin Detection W

  2026-06-04

  Streptavidin-HyperFluor 647 by APExBIO redefines sensitive biotin detection with exceptional signal-to-noise and workflow flexibility. Its low background and robust fluorescence empower advanced microscopy, flow cytometry, and FRET applications, now further contextualized by novel proximity labeling advances.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Application

  2026-06-04

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) provides researchers with a high-affinity, species-cross-reactive tool for detecting HMGB1 in human, mouse, and rat models. It is optimized for Western blot, immunohistochemistry, and flow cytometry applications focused on chromatin protein analysis. This reagent is strictly intended for research workflows and should not be used in diagnostic or therapeutic procedures.

• ARCA Cy3 EGFP mRNA (5-moUTP): Optimizing Mammalian Transfect

  2026-06-03

  ARCA Cy3 EGFP mRNA (5-moUTP) enables precise, real-time tracking of mRNA delivery, localization, and translation in mammalian cells. Its 5-methoxyuridine modification and Cy3 labeling provide researchers with a robust, immune-evasive, and direct-detection tool for assay optimization and workflow troubleshooting.

• CB-839 (Telaglenastat): Transforming Cancer Metabolism Resea

  2026-06-03

  CB-839 (Telaglenastat) is redefining how researchers interrogate glutamine metabolism in cancer, offering a potent and selective route to GLS1 inhibition. Its robust preclinical performance and unique utility in splicing/metabolic vulnerability studies mark it as a pivotal asset for advanced cancer metabolism research.

450 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page